Health
Azithromycin use for treating COVID-19 may increase risk of cardiac events – News-Medical.net
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest. Because of this, the U.S. Food and Drug Administration has revoked emergency use authorization for the drug in treating COVID-19.
Another drug, azithromycin — a commonly-prescribed antibiotic — also is being inves…
-
General22 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General7 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General19 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News23 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’